NVS:NYE-Novartis AG ADR (USD)

COMMON STOCK | Drug Manufacturers - General |

Last Closing

USD 109.35

Change

0.00 (0.00)%

Market Cap

N/A

Volume

1.11M

Analyst Target

USD 104.50
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-03 )

Largest Industry Peers for Drug Manufacturers - General

Symbol Name Price(Change) Market Cap
LLY Eli Lilly and Company

N/A

USD 813.31B
NVO Novo Nordisk A/S

N/A

USD 513.37B
JNJ Johnson & Johnson

N/A

USD 399.33B
ABBV AbbVie Inc

N/A

USD 359.54B
PFE Pfizer Inc

N/A

USD 163.54B
BMY Bristol-Myers Squibb Company

N/A

USD 110.17B
OGN Organon & Co

N/A

USD 4.84B
GSK GlaxoSmithKline PLC ADR

N/A

N/A
MRK Merck & Company Inc

N/A

N/A

ETFs Containing NVS

S2USBH:SW 14.68 % 0.00 %

N/A

N/A
S2EUBH:SW 14.66 % 0.00 %

N/A

N/A
S2USAH:SW 14.26 % 0.00 %

N/A

N/A
S2EUAH:SW 13.67 % 0.00 %

N/A

N/A
FLWR:SW 6.18 % 0.00 %

N/A

N/A
MEDX Horizon Kinetics Medical .. 5.76 % 0.00 %

N/A

N/A
LIFE-B:CA Evolve Global Healthcare .. 5.30 % 0.00 %

N/A

N/A
PPH VanEck Pharmaceutical ETF 5.17 % 0.36 %

N/A

USD 0.67B
DIVD Altrius Global Dividend E.. 2.42 % 0.00 %

N/A

N/A
DFIV Dimensional International.. 1.46 % 0.00 %

N/A

USD 7.85B
APIE Trust For Professional Ma.. 1.36 % 0.00 %

N/A

USD 0.80B
DFSI Dimensional International.. 0.95 % 0.00 %

N/A

N/A
AVSD American Century ETF Trus.. 0.89 % 0.00 %

N/A

USD 0.14B
DFAX Dimensional World ex U.S... 0.66 % 0.00 %

N/A

USD 7.17B
DBAW Xtrackers MSCI All World .. 0.00 % 0.41 %

N/A

N/A
DIM WisdomTree International .. 0.00 % 0.58 %

N/A

N/A
DPK 0.00 % 0.96 %

N/A

N/A
EFAV 0.00 % 0.20 %

N/A

N/A
EFO ProShares Ultra MSCI EAFE 0.00 % 0.95 %

N/A

USD 9.38M
EFU ProShares UltraShort MSCI.. 0.00 % 0.95 %

N/A

N/A
EFZ ProShares Short MSCI EAFE 0.00 % 0.95 %

N/A

N/A
EPV ProShares UltraShort FTSE.. 0.00 % 0.95 %

N/A

USD 0.02B
EUMV 0.00 % 0.25 %

N/A

N/A
FLQH 0.00 % 0.40 %

N/A

N/A
HDMV First Trust Horizon Manag.. 0.00 % 0.80 %

N/A

N/A
IQDF FlexShares International .. 0.00 % 0.47 %

N/A

N/A
OEUR 0.00 % 0.58 %

N/A

N/A
RFAP 0.00 % 0.83 %

N/A

N/A
RNDM 0.00 % 0.65 %

N/A

N/A
ACT Enact Holdings Inc 0.00 % 0.75 %

N/A

USD 5.04B
PTIN Pacer Trendpilot Internat.. 0.00 % 0.00 %

N/A

USD 0.15B
HHL-U:CA Harvest Healthcare Leader.. 0.00 % 0.00 %

N/A

N/A
PDEV 0.00 % 0.00 %

N/A

N/A
UPV ProShares Ultra FTSE Euro.. 0.00 % 0.95 %

N/A

N/A
HHL:CA Harvest Healthcare Leader.. 0.00 % 1.15 %

N/A

N/A
IS0P:F iShares V Public Limited .. 0.00 % 0.00 %

N/A

N/A
IS0S:F iShares III Public Limite.. 0.00 % 0.00 %

N/A

N/A
IS0P:XETRA iShares Spain Govt Bond U.. 0.00 % 0.00 %

N/A

USD 0.25B
IS0S:XETRA iShares Emerging Asia Loc.. 0.00 % 0.00 %

N/A

USD 0.15B
AVDE Avantis® International E.. 0.00 % 0.00 %

N/A

USD 5.20B
DFAI Dimensional International.. 0.00 % 0.00 %

N/A

USD 7.17B
FLWG:LSE 0.00 % 0.00 %

N/A

N/A
FLWR:LSE 0.00 % 0.00 %

N/A

N/A
BLUM:XETRA 0.00 % 0.00 %

N/A

N/A
HHL-B:CA Harvest Healthcare Leader.. 0.00 % 0.00 %

N/A

N/A
NTSI WisdomTree International .. 0.00 % 0.00 %

N/A

USD 0.34B
LEAD:CA Evolve Future Leadership .. 0.00 % 0.00 %

N/A

CAD 0.01B
LEAD-B:CA Evolve Future Leadership .. 0.00 % 0.00 %

N/A

CAD 0.02B
BLUM:F 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - General) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -45.85% 30% F 11% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -45.85% 30% F 12% F
Trailing 12 Months  
Capital Gain -41.06% 30% F 11% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -41.06% 30% F 11% F
Trailing 5 Years  
Capital Gain -37.08% 33% F 20% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -37.08% 33% F 21% F
Average Annual (5 Year Horizon)  
Capital Gain 3.33% 64% D 48% F
Dividend Return 7.05% 64% D 53% F
Total Return 3.72% 73% C 72% C
Risk Return Profile  
Volatility (Standard Deviation) 13.00% 91% A- 70% C-
Risk Adjusted Return 54.20% 64% D 71% C-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector